Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
Abstract Background Malaria control in sub-Saharan Africa relies upon prompt case management with artemisinin-based combination therapy (ACT). Ring-stage parasite mRNA, measured by sbp1 quantitative reverse-transcriptase PCR (qRT-PCR), was previously reported to persist after ACT treatment and hypot...
Main Authors: | Almahamoudou Mahamar, Kjerstin Lanke, Wouter Graumans, Halimatou Diawara, Koualy Sanogo, Kalifa Diarra, Sidi Mohamed Niambele, Roly Gosling, Chris Drakeley, Ingrid Chen, Alassane Dicko, Teun Bousema, Michelle E. Roh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-020-03576-z |
Similar Items
-
Phenotypic approach artemisinin resistance in malaria rodent as in vivo model
by: Lilik Maslachah, et al.
Published: (2017-07-01) -
Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
by: Tate Oulton, et al.
Published: (2022-12-01) -
Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
by: Hamma Maiga, et al.
Published: (2020-09-01) -
Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
by: David Dolivo, et al.
Published: (2021-02-01) -
Antitumor Research on Artemisinin and Its Bioactive Derivatives
by: Yunqin Zhang, et al.
Published: (2018-04-01)